Tight Timelines: The Biotech Existence

June 20, 2024

First Patient In 6 Weeks from Written Award

Learn how CRC partnered with an emerging biotech to overcome tight clinical timelines and successfully achieve the First Patient In milestone just 6 weeks from the written award. This case study showcases CRC’s rapid alignment, problem-solving capabilities, and operational excellence that not only met the sponsor’s stringent deadline but also boosted stakeholder confidence.

Download the full case study

< Older Post

Newer Post >
Dementia patient and doctor in clinical setting related to agitation trial

Mastering Agitation Endpoints with Assessment Expertise

July 30, 2025
Discover how CRC managed rater complexity and timelines in an agitation study using customized training and algorithmic oversight.
Alzheimer's patient with doctor

Seamless Execution Across Early-Phase Alzheimer’s Trials

July 15, 2025
Discover how CRC supported a novel Alzheimer’s program through first-in-human (FIH), Phase Ib/IIa, and OLE trials with precision, urgency, and trusted oversight.
Illustration of active brain neurons highlighting neural pathways

The Expanding Role of GLP-1 Receptor Agonists in CNS Clinical Research

July 1, 2025
GLP-1 receptor agonists may offer a new path for treating addiction and mental health challenges, emerging as a versatile class in CNS clinical research.
Show More